This clinical trial evaluates the ability of ultrasound compared to traditional cross-sectional imaging techniques in detecting of renal cell (kidney) cancer that has come back (recurrent). Ultrasound is a procedure in which high-energy sound waves are bounced off tissues to create a picture of internal body structures. It is unknown whether ultrasound is more or less effective at detecting recurrent kidney cancer than other imaging techniques such as computed tomography (CT) or magnetic resonance imaging (MRI). Ultrasound is more widely available than CT or MRI and may be a more cost effective method to use in the detection of recurrent kidney cancer.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04424472.
Locations matching your search criteria
United States
Kansas
Kansas City
University of Kansas Cancer CenterStatus: Active
Contact: Eugene Kang Lee
Phone: 913-945-6432
PRIMARY OBJECTIVE:
I. Compare the ability of ultrasound to cross-sectional imaging in the detection of intra-abdominal renal cell carcinoma recurrences.
SECONDARY OBJECTIVE:
I. Evaluate retrospective data for patients at University of Kansas Medical Center (KUMC) who underwent CT for surveillance imaging of surgically-resected renal cell carcinoma and determine the overall radiation burden if ultrasound were to be eliminated from surveillance guidelines.
OUTLINE:
Patients undergo ultrasound within 4 weeks of their most recent standard of care CT or MRI that detected disease recurrence.
Trial PhaseNo phase specified
Trial Typediagnostic
Lead OrganizationUniversity of Kansas Cancer Center
Principal InvestigatorEugene Kang Lee
